PO Box 58871
London SE15 9BE, UK
+44 (0)7794 485294

Cedilla Publishing highly commended at 2016 BMA Medical Book Awards
We are delighted to announce that our GP pain handbook, The 10-minute consultation: persistent pain, was highly commended in the primary health care category at the 2016 BMA Medical Book Awards.

The GP judging panel commented:
"Pain management is an increasingly challenging field in general practice and this [guide] brings together a lot of useful information. It is comprehensive while concise and includes a good range from the best scientific evidence through to holistic approaches. I checked some of the sections and found them to be both accurate and up-to-date. It is a good introduction to the subject."

If you are interested in purchasing copies or translation rights, please contact Sarah Findlay on +44 (0)7794 485294 or email info@cedillapublishing.com.

News Archive

Sit-down meals 'less healthy than fast-food'
Thu, 13 Dec 2018 00:52:32 GMT
Only one in 10 meals was classed as healthy which is a cause for concern, say researchers.
Organ donors to be asked if they are religious
Thu, 13 Dec 2018 00:04:09 GMT
It is hoped the measure can boost the low proportion of donors from black and Asian backgrounds.
Royal Cornwall Hospital on Opel 4 highest alert for 134 days
Wed, 12 Dec 2018 00:13:43 GMT
A woman's hysterectomy was postponed four times at a hospital experiencing extreme pressures.
NICE rejects NHS funding for Tegsedi, Onpattro
Wed, 12 Dec 2018 23:04:57 +0000
The National Institute for Health and Care Excellence has issued draft guidelines rejecting NHS funding for two therapies that treat the rare inherited condition hereditary transthyretin-related amyliodsis (hATTR).
Experts call for national lung disease plan
Wed, 12 Dec 2018 23:01:18 +0000
Experts are calling for a national review and action plan to tackle lung disease to help ease annual winter pressures on the NHS.
AstraZeneca, AVEO Oncology form lung cancer collaboration
Wed, 12 Dec 2018 22:58:27 +0000
AVEO Oncology has announced the start of an immuno-oncology focused clinical collaboration with drug giant AstraZeneca (AZ).